An Enhanced Vaginal Dilator to Reduce Radiation-Induced Vaginal Stenosis
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Endometrial Cancer
Related studies linked through entity extraction aliases.
Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Sentinel Node Detection in Endometrial Cancer: A Consolidation Study on Detection Rates of Metastatic Disease
- Status
- UNKNOWN
- Phase
- NA
Mirvetuximab Soravtansine (IMGN853) and Bevacizumab in Patients With Endometrial Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Phase 2 Study of Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors
- Status
- UNKNOWN
- Phase
- PHASE2
Urinary miRNA in Endometrial Cancer Study
- Status
- COMPLETED
- Phase
- N/A
MOtiVating Endometrial Cancer Survivors With Activity Monitors and Tailored Feedback
- Status
- COMPLETED
- Phase
- NA
Anxiety and Distress Levels in Women With Suspected Endometrial Cancer
- Status
- COMPLETED
- Phase
- N/A
The Multicentic Trial in Fertility-sparing Treatment and Ovarian Preservation Management for Early Endometrial Cancer
- Status
- UNKNOWN
- Phase
- NA
Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
- Status
- RECRUITING
- Phase
- NA
Vaginal Cuff Brachytherapy Fractionation Study
- Status
- RECRUITING
- Phase
- PHASE3
Exploring the Potential of Novel Biomarkers Based on Plasma microRNAs for a Better Management of Pelvic Gynecologic Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Application of Tachosil During Lymphadenectomy
- Status
- COMPLETED
- Phase
- PHASE4
Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1 Study of [225Ac]-FPI-1434 Injection
- Status
- TERMINATED
- Phase
- PHASE1
MSI in Circulatory DNA of Endometrial Cancer
- Status
- UNKNOWN
- Phase
- N/A
Telehealth-Based Resistance Training Intervention for Endometrial Cancer Survivors
- Status
- COMPLETED
- Phase
- NA
Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial Cancer
- Status
- TERMINATED
- Phase
- EARLY_PHASE1